Malignant neoplasm of other and ill-defined digestive organs Clinical Trials

8 clinical trials for Malignant neoplasm of other and ill-defined digestive organs across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Cross-institutional, prospective, open label, single group basket study of combined CRAF and MEK inhibition in advanced-stage malignancies harboring BRAF mutations with impaired kinase activity — RECRUITING
• Dynamics of circulating tumor DNA (ctDNA) and extracellular vesicle (EVs) for diagnosis, therapy monitoring, and prognosis assessment in solid visceral tumors. — RECRUITING
• Network Oncology - therapy accompanying evaluation of health services research in integrative oncolgy — RECRUITING
• Reliability tEstinG of diGital pAtient-reported-experience mEasures (PREMs) - the randomized controlled REGGAE trial — RECRUITING
• Prediction of intestinal anastomotic leakage via liquid biopsy - a prospective cohort study (PRAY) — OTHER
• Advanced non-invasive monitoring for individual and patient-adapted anesthesia management — NOT_YET_RECRUITING
• Influence of the severity of postoperative complications after major visceral surgery on the length of hospital stay — OTHER
• Analysis of physical activity of colon- and lungcancer patients during or after therapy, during the second coronalockdown (COVID-19) in spring 2021, in comparison to the, by the S3 guidelines and the WHO recommended minimum of physical activity — NOT_YET_RECRUITING

Refine this search